BioCentury
ARTICLE | Financial News

Angiotech up on paclitaxel deal

August 21, 2001 7:00 AM UTC

Angiotech (ANPI; TSE:ANP) was up $6.96 (14%) to $55.96 in NASDAQ trading on Tuesday following an after market announcement on Monday that Guidant (GDT) received exclusive worldwide distribution rights...